| 2026-03-31 |
股东大会：
将于2026-04-28召开股东大会
会议内容 ▼▲
- 1.To approve, by separate ordinary resolutions, the election and re-election of the following persons as directors of the Company (the “Directors”) to serve for a three-year term or until they cease to be Director in accordance with the articles of association of the Company;
2.To ratify, by ordinary resolution, the appointment of MRI Moores Rowland LLP (“MRI”) as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2025, and to authorize the Board of Directors to fix the remuneration of MRI.
3.To transact such other business as may properly come before the meeting.
|
| 2025-10-30 |
股东大会：
将于2025-11-26召开股东大会
会议内容 ▼▲
- 1.To approve, as a special resolution, an alteration to the share capital of the Company by:adopting the third amended and restated memorandum of association (the “Third Amended and Restated Memorandum of Association”) and the second amended and restated articles of association (the “Second Amended and Restated Articles of Association”) of the Company, in the forms of Appendices A and B, respectively, to this Notice of Extraordinary General Meeting, as the memorandum and articles of association of the Company, in substitution for, and to the exclusion of, the existing Second Amended and Restated Memorandum of Association and Amended and Restated Articles of Association, respectively, of the Company (the “M&A Amendment and Restatement”, and together with the Redesignation of Share Capital, the “Share Capital Alteration”).
2.To approve, as an ordinary resolution, a share consolidation of every issued and unissued ordinary share of par value US$0.0001 each of the Company (including the Class A Ordinary Shares and Class B Ordinary Shares upon the Redesignation of Share Capital taking effect) at a ratio of not less than one (1)-for-two (2) and not more than one (1)-for-twenty (20) (the “Range”), with the exact ratio to be set at a whole number within the Range by the board of directors of the Company (the “Board of Directors”) in its sole discretion and the effective date of such share consolidation (the “Effective Date”) to be determined by the Board of Directors in its sole discretion, but in no event shall the Effective Date occur later than August 27, 2026 (the “Share Consolidation”).
3.To approve, as an ordinary resolution, to adjourn the Extraordinary General Meeting for any purpose, including to solicit additional proxies if there are insufficient votes at the time of the Extraordinary General Meeting to approve the proposals described above (the “Adjournment”).
|
| 2025-09-02 |
详情>>
股本变动：
变动后总股本2750.03万股
|
| 2025-09-02 |
详情>>
业绩披露：
2025年中报每股收益-0.04美元,归母净利润-97.29万美元,同比去年增长36.58%
|
| 2025-04-16 |
详情>>
业绩披露：
2024年年报每股收益-0.14美元,归母净利润-373.6万美元,同比去年增长-427.94%
|
| 2025-03-20 |
股东大会：
将于2025-04-23召开股东大会
会议内容 ▼▲
- 1.To approve, by separate ordinary resolutions, the re-election of the following persons as directors of the Company (the “Directors”) to serve for a three-year term or until they cease to be Directors in accordance with the articles of association of the Company:a.Mr. Logeswaran Ramasamy.b.Ms. Karen Yee Lynn Cheah.
2.To ratify, by ordinary resolution, the appointment of MRI Moores Rowland LLP (“MRI”) as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2024, and to authorize the Board of Directors to fix the remuneration of MRI.
3.To transact such other business as may properly come before the meeting.
|
| 2024-09-12 |
详情>>
业绩披露：
2024年中报每股收益-0.06美元,归母净利润-153.41万美元,同比去年增长-233%
|
| 2024-04-18 |
详情>>
业绩披露：
2023年年报每股收益0.04美元,归母净利润113.92万美元,同比去年增长-69.08%
|
| 2024-03-20 |
股东大会：
将于2024-04-24召开股东大会
会议内容 ▼▲
- 1.To approve, by separate ordinary resolutions, the re-election of the following persons as directors of the Company (the “Directors”) to serve until they cease to be Directors in accordance with the articles of association of the Company:a.Mr. Teck Lim Chia;b.Mr. Koon Liang Ong;c.Mr. Khai Fei Wong.
2.To ratify, by ordinary resolution, the appointment of MRI Moores Rowland LLP (“MRI”) as the Company’s independent registered public accounting firm effective February 23, 2024 and for the fiscal year ended December 31, 2022 & 2023, and to authorize the board of Directors to fix the remuneration of MRI.
3.To transact such other business as may properly come before the meeting.
|
| 2023-10-04 |
股东大会：
将于2023-11-06召开股东大会
会议内容 ▼▲
- 1.To approve, by separate ordinary resolutions, the re-election of the following persons as directors of the Company (the “Directors”) to serve until they cease to be Directors in accordance with the articles of association of the Company (the “Articles of Association”):
Mr. Teck Lim Chia, Mr. Logeswaran Ramasamy, Dato’ Sri Kam Choy Ho, Mr. Ulf Lothar Naujeck, Ms. Karen Yee Lynn Cheah, Mr. Koon Liang Ong, Mr. Khai Fei Wong.
2.To ratify, by ordinary resolution, the appointment of MSPC Certified Public Accountants and Advisors, P.C. (“MSPC CPA”) as the Company’s independent registered public accounting firm effective June 23, 2023 and for the fiscal year ending December 31, 2023, and to authorize the board of Directors to fix the remuneration of MSPC CPA.
3.To amend, by special resolution, the existing Articles of Association to: (i) allow general meetings to be held as a physical meeting, hybrid meeting or a virtual meeting where shareholders may attend by electronic means in addition to being present in person physically; (ii) allow for the publication of the notices of general meetings and other corporate communication on the Company’s website; and (iii) require one-third of the Directors to retire from office and offer themselves for re-election at each annual general meeting of the Company, details of which are set out in the Schedule hereto attached.
4.To transact such other business as may properly come before the meeting.
|
| 2023-09-14 |
详情>>
业绩披露：
2023年中报每股收益0.05美元,归母净利润115.34万美元,同比去年增长5.93%
|
| 2023-07-12 |
复牌提示：
2023-07-12 09:53:58 停牌，复牌日期 2023-07-12 09:58:58
|
| 2023-04-26 |
详情>>
业绩披露：
2022年年报每股收益0.17美元,归母净利润368.50万美元,同比去年增长3.25%
|
| 2022-09-20 |
详情>>
业绩披露：
2022年中报每股收益0.05美元,归母净利润108.89万美元,同比去年增长-24.48%
|
| 2022-09-20 |
详情>>
业绩披露：
2021年年报每股收益7.28美元,归母净利润356.90万美元,同比去年增长24.02%
|